Allison Dorval - 15 Jul 2021 Form 4 Insider Report for Aerovate Therapeutics, Inc. (AVTE)

Role
Director
Signature
/s/ George A. Eldridge, Attorney-in-Fact
Issuer symbol
AVTE
Transactions as of
15 Jul 2021
Transactions value $
$0
Form type
4
Filing time
19 Jul 2021, 16:28:57 UTC
Next filing
30 Nov 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVTE Stock Option (Right to Buy) Award $0 +25,000 $0 25,000 15 Jul 2021 Common Stock 25,000 $14.82 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest in 36 substantially equal monthly installments, with the first installment vesting on August 15, 2021.